Magnetar Financial LLC Purchases 1,377,929 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Magnetar Financial LLC boosted its position in Option Care Health, Inc. (NASDAQ:OPCH) by 124.8% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,481,935 shares of the company’s stock after acquiring an additional 1,377,929 shares during the period. Option Care Health accounts for about 1.4% of Magnetar Financial LLC’s holdings, making the stock its 22nd biggest position. Magnetar Financial LLC’s holdings in Option Care Health were worth $68,750,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Principal Securities Inc. bought a new position in Option Care Health in the 4th quarter valued at about $27,000. Parallel Advisors LLC lifted its stake in Option Care Health by 130.2% during the 4th quarter. Parallel Advisors LLC now owns 845 shares of the company’s stock valued at $28,000 after acquiring an additional 478 shares in the last quarter. TFO Wealth Partners LLC boosted its holdings in Option Care Health by 24,625.0% during the 4th quarter. TFO Wealth Partners LLC now owns 989 shares of the company’s stock worth $33,000 after acquiring an additional 985 shares during the last quarter. Park Place Capital Corp grew its stake in shares of Option Care Health by 48.4% in the 1st quarter. Park Place Capital Corp now owns 1,140 shares of the company’s stock worth $38,000 after acquiring an additional 372 shares in the last quarter. Finally, Blue Trust Inc. raised its holdings in shares of Option Care Health by 14.8% in the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock valued at $81,000 after purchasing an additional 377 shares during the last quarter. Institutional investors own 98.05% of the company’s stock.

Option Care Health Stock Performance

NASDAQ:OPCH opened at $31.90 on Monday. Option Care Health, Inc. has a 1 year low of $26.11 and a 1 year high of $34.63. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.76 and a quick ratio of 1.36. The business has a fifty day simple moving average of $31.20 and a two-hundred day simple moving average of $30.44. The company has a market capitalization of $5.54 billion, a P/E ratio of 20.99, a P/E/G ratio of 2.46 and a beta of 1.29.

Option Care Health (NASDAQ:OPCH) last issued its earnings results on Wednesday, July 31st. The company reported $0.30 earnings per share for the quarter, topping analysts’ consensus estimates of $0.27 by $0.03. Option Care Health had a net margin of 4.60% and a return on equity of 14.82%. The firm had revenue of $1.23 billion during the quarter, compared to analyst estimates of $1.17 billion. During the same quarter last year, the business earned $0.63 earnings per share. The company’s quarterly revenue was up 14.8% on a year-over-year basis. On average, analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Insider Activity at Option Care Health

In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the sale, the director now owns 21,339 shares in the company, valued at $663,429.51. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, CFO Michael H. Shapiro sold 23,217 shares of the company’s stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total transaction of $718,566.15. Following the sale, the chief financial officer now owns 247,317 shares of the company’s stock, valued at approximately $7,654,461.15. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the firm’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the transaction, the director now directly owns 21,339 shares of the company’s stock, valued at $663,429.51. The disclosure for this sale can be found here. 0.64% of the stock is owned by company insiders.

Analysts Set New Price Targets

OPCH has been the subject of a number of recent analyst reports. Barrington Research upped their price objective on shares of Option Care Health from $38.00 to $40.00 and gave the stock an “outperform” rating in a research report on Thursday, August 1st. JMP Securities started coverage on Option Care Health in a research report on Tuesday, July 16th. They issued an “outperform” rating and a $36.00 price objective on the stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.